Researchers analyzed cardiovascular risk comorbidities among patients with rheumatoid arthritis, and the correlation between CV risk and the use of antirheumatic drugs.
Researchers evaluated the association between hydroxychloroquine and risk for incident atrial fibrillation in patients with systemic lupus erythematosus.
Researched analyzed the risk for adverse cardiovascular events and death with febuxostat vs allopurinol in patients with gout.
Researchers evaluated the cardiovascular safety of hydroxychloroquine in patients with rheumatoid arthritis before the COVID-19 pandemic.
Bone mineral density (BMD) has independent prognostic value for predicting atherosclerotic cardiovascular disease (ASCVD) in women.
Researchers studied the association between maternal hypertensive disorders and risk for cardiovascular outcomes in women with systemic lupus erythematosus.
In this study, researchers assess the connection between bone fragility and major adverse coronary events in older men.
CVD risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis.
A comprehensive meta-analysis quantified the risks of several cardiovascular diseases in patients with systemic lupus erythematosus (SLE).
Patients with systemic lupus erythematosus have a higher risk for cardiovascular events and mortality.